The 4th Risk Evaluation and Mitigation Strategies Summit (REMS) covers topics such as:
- A thorough assessment of the European guidance Module 16
- The FDAs newly released REMS Standardization Report
- Case studies on best practices, lessons learned, and successful strategies and tools for REMS design , development and modification by a cross section of small to large companies
- How to overcome challenges in a single shared REMS from experienced professionals
- How REMS is managed by hospitals and pharmacy organizations
The 4th Risk Evaluation and Mitigation Strategies Summit (REMS) brings together attendees involved or interested in
- Risk Management
- REMS
- Epidemiology/Pharmacoepidemiology
- Pharmacovigilance/Surveillance
- Quality Assurance
- Pharmacoeconomics
- Clinical Risk Management
- Drug/Product Safety
- Regulatory Affairs
- Lifecycle Management
- Clinical Data Management
- Clinical Affairs
- Clinical Risk Management Compliance
- Clinical Operations
- Marketing
- Medical Writing/Communications
and also attendees from:
- Contract Research Organizations
- REMS/Drug Safety Service Providers
- Technology Vendors
- Data Management Services
- Drug Safety & Risk Management Services
- Pharmaceutical Consultants
- Health Services Research and Academics
- Health Care Regulators and Policy Makers
- Speaker Bureaus
- Lifecycle Management Services
The 4th Risk Evaluation and Mitigation Strategies Summit (REMS) might be held in United States in 2024.
